NEVRO CORP.

Nevro Corp. specializes in the design, manufacturing, and supply of advanced neurostimulation systems for chronic pain management, with a focused technical expertise in spinal cord stimulation devices and associated implantable pulse generators. Their core capabilities center on electromedical hardware development, including fully implanted neurostimulation systems such as the Senza OmniA™ platform, which delivers high-frequency therapeutic signals to modulate pain pathways. The company demonstrates deep proficiency in surgical-grade medical device manufacturing, integrating precision engineering, biocompatible materials, and closed-loop control systems compliant with FDA and ISO 13485 standards. Their differentiation lies in the integration of implantable hardware with clinical workflows for post-surgical care, enabling targeted neuromodulation therapies used in complex spinal interventions. Nevro Corp. maintains a consistent and primary relationship with the Department of Veterans Affairs, supplying spinal cord stimulators and related surgical implants for veterans receiving chronic pain treatment. These procurements reflect long-term, repeat engagements for high-acuity neurological devices used in VA medical centers. A single award from the Department of Defense underscores their capability to support military healthcare facilities, such as Walter Reed, with mission-critical neuromodulation systems for service members. The company operates primarily within NAICS 339113 (surgical appliance and supplies manufacturing) and 339112 (surgical and medical instrument manufacturing), positioning itself as a niche provider of Class III implantable medical devices. Their market focus is on neuromodulation therapies, specifically spinal cord stimulation systems used in interventional pain management, distinguishing them in the broader electromedical equipment sector. Nevro Corp. is a privately held entity headquartered in Redwood City, California, with no publicly disclosed federal certifications. Their geographic presence is centered in the U.S. medical device corridor, with direct supply chains supporting federal healthcare delivery systems through specialized distribution channels.